I think of great significance, which you have missed here is the following...from the ann...
"OnCARlytics can enhance the expression of CD19 on solid tumours. Azer-cel is a supercharged allogeneic T cell designed to identify
and kill malignant cells expressing CD19. We are thrilled about the potential benefit for patients from the combination of these two technologies.”"
Why is LC talking about Solid tumours, in an announcement about the procurement of a liquid (Blood cancer)?
I think the value of this allogeniec T cell platform goes beyond the one product, it is a way of IMU not having to
partner with any other Car-t company in getting into solid tumour market.
I think of great significance, which you have missed here is the...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.0¢ |
Change
-0.001(1.41%) |
Mkt cap ! $512.3M | |||
| Open | High | Low | Value | Volume |
| 7.0¢ | 7.1¢ | 6.8¢ | $922.0K | 13.28M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 702419 | 7.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.1¢ | 1365317 | 9 |
View Market Depth
| Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.0¢ |
Change
-0.001 ( 1.69 %) |
||||
| Open | High | Low | Volume | ||
| 7.0¢ | 7.1¢ | 6.8¢ | 5455105 | ||
| Last updated 15.59pm 24/05/2024 ? | |||||
| IMU (ASX) Chart |